Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305695200 on August 11, 2003

J. Biol. Chem., Vol. 278, Issue 43, 42679-42685, October 24, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
278/43/42679    most recent
M305695200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Razzaq, T. M.
Right arrow Articles by Ellis, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Razzaq, T. M.
Right arrow Articles by Ellis, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Regulation of Tissue Plasminogen Activator on the Surface of Vascular Smooth Muscle Cells by the Type-II Transmembrane Protein p63 (CKAP4)*

Tahir M. Razzaq{ddagger}, Rosemary Bass, David J. Vines§, Finn Werner, Simon A. Whawell||, and Vincent Ellis**

From the School of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, United Kingdom

We have demonstrated that tissue plasminogen activator (tPA) binds specifically to human vascular smooth muscle cells (VSMC) in a functionally relevant manner, both increasing plasminogen activation and decreasing tPA inhibition (Ellis, V., and Whawell, S. A. (1997) Blood 90, 2312-2322; Werner, F., Razzaq, T. M., and Ellis, V. (1999) J. Biol. Chem. 274, 21555-21561). To further understand this system we have now identified and characterized the protein responsible for this binding. Rat VSMC were surface-labeled with 125I, and cell lysates were subjected to an affinity chromatography scheme based on the previously identified tPA binding characteristics. A single radiolabeled protein of 63 kDa bound specifically and was eluted at low pH. This protein was isolated from large scale preparations of VSMC and unambiguously identified as the rat homologue of the human type-II transmembrane protein p63 (CKAP4) by matrix-assisted laser desorption ionization and nano-electrospray tandem mass spectrometry of tryptic fragments. In confirmation of this, a monoclonal antibody raised against authentic human p63 recognized the isolated protein in Western blotting. Immunofluorescence microscopy demonstrated that p63 was located principally in the endoplasmic reticulum but was also detected in significant quantities on the surface of human VSMC. In support of the hypothesis that p63 is the functional tPA binding site on VSMC, an anti-p63 monoclonal antibody was found to block tPA binding. Furthermore, heterologous expression of an N-terminally truncated mutant of p63, which targets exclusively to the plasma membrane, led to an increase in tPA-catalyzed plasminogen activation. Therefore, p63 on the surface of VSMC may contribute to the functional regulation of the plasminogen activation system in the vessel wall.


Received for publication, May 30, 2003 , and in revised form, July 10, 2003.

* This work was funded by British Heart Foundation Grants PG/96041 and PG/98172. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains a sequence comparison of rat and human p63 (CKAP4).

{ddagger} Present address: Dept. of Experimental Haematology, The Royal London Hospital Medical School, London E1 2AD, United Kingdom.

§ Present address: Ludwig Inst. for Cancer Research, University College London, London W1W 7BS, United Kingdom.

Present address: Dept. of Biological Sciences, Imperial College London, London SW7 2AZ, United Kingdom.

|| Present address: Eastman Dental Inst., University College London, London WC1X 8LD, United Kingdom.

** Senior Research Fellow of the British Heart Foundation and to whom correspondence should be addressed. Tel.: 44-1603-592570; Fax: 44-1603-592250; E-mail: v.ellis{at}uea.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. L. Planey, S. K. Keay, C.-O. Zhang, and D. A. Zacharias
Palmitoylation of Cytoskeleton Associated Protein 4 by DHHC2 Regulates Antiproliferative Factor-mediated Signaling
Mol. Biol. Cell, March 1, 2009; 20(5): 1454 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. R. Bates, A. S. Kazi, J.-Q. Tao, K. J. Yu, D. S. Gonder, S. I. Feinstein, and A. B. Fisher
Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L658 - L669.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. Zhang, S. L. Planey, C. Ceballos, S. M. Stevens Jr., S. K. Keay, and D. A. Zacharias
Identification of CKAP4/p63 as a Major Substrate of the Palmitoyl Acyltransferase DHHC2, a Putative Tumor Suppressor, Using a Novel Proteomics Method
Mol. Cell. Proteomics, July 1, 2008; 7(7): 1378 - 1388.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. G. Gugiu, K. Mouillesseaux, V. Duong, T. Herzog, A. Hekimian, L. Koroniak, T. M. Vondriska, and A. D. Watson
Protein targets of oxidized phospholipids in endothelial cells
J. Lipid Res., March 1, 2008; 49(3): 510 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. P. Conrads, G. M. Tocci, B. L. Hood, C.-O. Zhang, L. Guo, K. R. Koch, C. J. Michejda, T. D. Veenstra, and S. K. Keay
CKAP4/p63 Is a Receptor for the Frizzled-8 Protein-related Antiproliferative Factor from Interstitial Cystitis Patients
J. Biol. Chem., December 8, 2006; 281(49): 37836 - 37843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Gupta, Y. Manevich, A. S. Kazi, J.-Q. Tao, A. B. Fisher, and S. R. Bates
Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L436 - L446.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
V M Diaz, M Hurtado, T M Thomson, J Reventos, and R Paciucci
Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro
Gut, July 1, 2004; 53(7): 993 - 1000.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement